Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Scott

Showing results (251-260 of 327) with videos related to

Pageof 33
Sort By:
The Biochemical Journal|September 26, 2018
Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutantsDiego Avellaneda Matteo, Grace A Wells, Lucas A Luna, et al.
The Journal of Cell Biology|September 2, 2022
Origin of cytoplasmic GDP-fucose determines its contribution to glycosylation reactionsPaulina Sosicka, Bobby G Ng, Lauren E Pepi, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitorsTao Wang, Stephanos Ioannidis, Lynsie Almeida, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitorDavid A Scott, Les A Dakin, David J Del Valle, et al.
Science (New York, N.Y.)|December 8, 2018
Functionally diverse type V CRISPR-Cas systemsWinston X Yan, Pratyusha Hunnewell, Lauren E Alfonse, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2008
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancerDavid A Scott, Brian M Aquila, Geraldine A Bebernitz, et al.
Advances in Therapy|December 9, 2021
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled TrialsJuan Jose Garcia Sanchez, Juliette Thompson, David A Scott, et al.
British Journal of Cancer|May 13, 2021
Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapyShegan Gao, Yiwen Liu, Xiaoxian Duan, et al.
Nature|April 2, 2015
In vivo genome editing using Staphylococcus aureus Cas9F Ann Ran, Le Cong, Winston X Yan, et al.
Nature Biotechnology|April 23, 2014
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cellsXuebing Wu, David A Scott, Andrea J Kriz, et al.
Pageof 33

Showing results (251-260 of 327) with videos related to

Sort By:
Pageof 33
The Biochemical Journal|September 26, 2018
Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutantsDiego Avellaneda Matteo, Grace A Wells, Lucas A Luna, et al.
The Journal of Cell Biology|September 2, 2022
Origin of cytoplasmic GDP-fucose determines its contribution to glycosylation reactionsPaulina Sosicka, Bobby G Ng, Lauren E Pepi, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitorsTao Wang, Stephanos Ioannidis, Lynsie Almeida, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitorDavid A Scott, Les A Dakin, David J Del Valle, et al.
Science (New York, N.Y.)|December 8, 2018
Functionally diverse type V CRISPR-Cas systemsWinston X Yan, Pratyusha Hunnewell, Lauren E Alfonse, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2008
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancerDavid A Scott, Brian M Aquila, Geraldine A Bebernitz, et al.
Advances in Therapy|December 9, 2021
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled TrialsJuan Jose Garcia Sanchez, Juliette Thompson, David A Scott, et al.
British Journal of Cancer|May 13, 2021
Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapyShegan Gao, Yiwen Liu, Xiaoxian Duan, et al.
Nature|April 2, 2015
In vivo genome editing using Staphylococcus aureus Cas9F Ann Ran, Le Cong, Winston X Yan, et al.
Nature Biotechnology|April 23, 2014
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cellsXuebing Wu, David A Scott, Andrea J Kriz, et al.
Pageof 33